Yu H - Search Results

1

[Prognostic factors of invasive non-Hodgkin's lymphoma].

Yu H, Hong XN, Li J, Peng LP, Ye L. Yu H, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):461-3. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974284 Chinese.

2

Continuous infusion of 5-FU with split-dose cisplatin: an effective treatment for advanced squamous-cell carcinoma of the head and neck.

Luo Z, Chang J, Guo Y, Yu H, Lu F, Wu X, Li J. Luo Z, et al. Among authors: yu h. Clin Invest Med. 2011 Feb 1;34(1):E8-13. doi: 10.25011/cim.v34i1.14907. Clin Invest Med. 2011. PMID: 21291636 Clinical Trial.

3

A single institution, retrospective study of treatment experience in primary mediastinal germ cell tumors: elucidating the significance of systemic chemotherapy.

Wang JL, Yu H, Guo Y, Hu XC, Pan ZQ, Chang JH, Zhang YW. Wang JL, et al. Among authors: yu h. Chin Med J (Engl). 2012 Feb;125(4):626-30. Chin Med J (Engl). 2012. PMID: 22490486

4

A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer.

Yu H, Zhang J, Wu X, Luo Z, Wang H, Sun S, Peng W, Qiao J, Feng Y, Wang J, Chang J. Yu H, et al. Cancer Biol Ther. 2014 Jul;15(7):832-9. doi: 10.4161/cbt.28874. Epub 2014 Apr 22. Cancer Biol Ther. 2014. PMID: 24755888 Free PMC article. Clinical Trial.

5

Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.

Zhu X, Zhao X, Peng W, Sun S, Cao J, Ji D, Liu X, Wang C, Huang M, Yu H, Guo W, Li J, Yin J. Zhu X, et al. Among authors: yu h. J Cancer Res Clin Oncol. 2015 Jan;141(1):109-18. doi: 10.1007/s00432-014-1754-8. Epub 2014 Jul 18. J Cancer Res Clin Oncol. 2015. PMID: 25035248 Clinical Trial.

6

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma.

Luo Z, Zhang X, Peng W, Wu X, Wang H, Yu H, Wang J, Chang J, Hong X. Luo Z, et al. Among authors: yu h. Medicine (Baltimore). 2015 Oct;94(43):e1777. doi: 10.1097/MD.0000000000001777. Medicine (Baltimore). 2015. PMID: 26512574 Free PMC article. Clinical Trial.

7

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors.

Zhao X, Wu X, Yu H, Wang H, Sun S, Hu Z, Liu C, Zhang J, Shao Y, Wang J. Zhao X, et al. Among authors: yu h. Front Immunol. 2022 Oct 20;13:1003581. doi: 10.3389/fimmu.2022.1003581. eCollection 2022. Front Immunol. 2022. PMID: 36341410 Free PMC article.

8

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.

Wang J, Chang J, Yu H, Wu X, Wang H, Li W, Ji D, Peng W. Wang J, et al. Among authors: yu h. Cancer Chemother Pharmacol. 2013 Apr;71(4):905-11. doi: 10.1007/s00280-013-2081-5. Epub 2013 Feb 1. Cancer Chemother Pharmacol. 2013. PMID: 23370661 Clinical Trial.

9

[Effect of hexamethylene bisacetamine on proliferation and apoptosis of human leukemia cells in vitro and relevant mechanisms].

Yu H, Lu H, Zheng B, Fan H, Xie Y. Yu H, et al. Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):549-52. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133503 Chinese.

10

A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.

Xing K, Zhou X, Zhao X, Sun S, Luo Z, Wang H, Yu H, Wang J, Chang J, Wu X, Hu A. Xing K, et al. Among authors: yu h. Med Oncol. 2014 Jul;31(7):36. doi: 10.1007/s12032-014-0036-2. Epub 2014 Jun 8. Med Oncol. 2014. PMID: 24908064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,489 results

Search Page

Filters